Purpose The image quality characteristics of a NEMA body phantom with yttrium-90 were evaluated on a total body PET/CT. The purpose of the study is to identify the optimized reconstruction setup for the imaging protocol of yttrium-90 radioembolization treatment on patients with malignant liver tumors. Methods Two NEMA IEC NU2 body phantoms were used for the study. One was filled with activity concentrations of 0.13 MBq/ml and 1.3 MBq/ml for the background and spheres respectively (ratio 1:10). The second one did not have any background concentration but had similar concentration for the spheres. Scan time was 50 minutes and the phantoms were positioned on the same bed and scanned simultaneously. The number of iterations varied from 2 up to 8 (5 subsets), the Gaussian filter from 2mm up to 6mm full-width-at-half-maximum. Images were reconstructed with a matrix of 440 x 440 and 220 x 220, with high sensitivity (HS) and ultra-high sensitivity (UHS) modes with the improved 3D scatter correction method. We simulated shorter acquisition times based on the list-mode data with 40, 30, 20, 10 and 5-minutes. The measurements included contrast recovery coefficients, signal-to-noise ratio, background variability and lung error. List mode data of a patient were rebinned in 1, 5, 10 and 20 minute time frames and evaluated. Results The recovery coefficient (RC) for the hot phantom was 0.36, 0.45, 0.53, 0.63, 0.68 and 0.84 for the spheres with diameters of 10, 13, 17, 22, 28, 37 mm respectively for UHS 2 iterations and a 220x220 matrix. The SNR was highest for 2 iterations, measured 11.7, 16.6, 17.6, 19.4, 21.9 and 27.7 and the lung error was 18%. The SNR was 19%, 20%, 24% and 31% higher for 2 iterations compared to 4 iterations for 20, 10, 5 and 1 minutes time frames respectively. Conclusions The long AFOV delivers images of Y-90 with the smallest sphere well visualized with a high RC. SNR for the patient data was maximum for 2 iterations and for 20-minutes acquisition while even 5-minutes acquisition time delivers images with no great loss of SNR (-20%). Further clinical investigation is recommended to check also the effects on post-treatment dosimetry validation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.